UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016521
Receipt number R000019184
Scientific Title Effecs of Pectoral major plane block in breast cancer patients treated with partial mastectomy and sentinel node biopsy: comparison of postoperative pain with or without the block, Randomized Controlled Trial
Date of disclosure of the study information 2015/02/12
Last modified on 2016/03/25 08:47:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effecs of Pectoral major plane block in breast cancer patients treated with partial mastectomy and sentinel node biopsy: comparison of postoperative pain with or without the block, Randomized Controlled Trial

Acronym

Effecs of Pectoral major plane block in breast cancer patients treated with partial mastectomy and sentinel node biopsy: comparison of postoperative pain with or without the block, Randomized Controlled Trial

Scientific Title

Effecs of Pectoral major plane block in breast cancer patients treated with partial mastectomy and sentinel node biopsy: comparison of postoperative pain with or without the block, Randomized Controlled Trial

Scientific Title:Acronym

Effecs of Pectoral major plane block in breast cancer patients treated with partial mastectomy and sentinel node biopsy: comparison of postoperative pain with or without the block, Randomized Controlled Trial

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Surgery in general Anesthesiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The pectoral nerves block type 1 and 2 are novel approach to block the pectoral, intercostobrachial, 3rd to 6th intercostals, and the long thoracic nerves. But the effect of nerves block is insufficient of parasternal area, close to nipple. The anterior branches of the intercostal nerves innervates the inner aspects of pectoralis major muscles (PMm). The aim to block the anterior branches of the intercostal nerves, local anesthetic is deposited to the plane of PMm (PMPB).
Our study prospectively compares the effect of analgesia in and after partial mastectomy with sentinel lymphadenectomy using US guided Pecs block undesr general anesthesia versus PMPB with Pecs block under general anesthesia.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) NRS
2) SF-MPQ2

Key secondary outcomes

1) Consumption of intraoperative analgesic agent
2) Consumption of postoperative analgesic agent
3) Severity of PONV using a Likert scale (none, mild, moderate, and severe)


Base

Study type


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

US guided pectoral nerves block (pecs 1 block and pecs 2 block) and PMPB (pectoral major muscle plane block ) preoperatively under general anesthesia.

Interventions/Control_2

US guided pectoral nerves block (pecs 1 block and pecs 2 block) preoperatively under general anesthesia.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1. America Society of Anesthesiologist physical status (ASA-PS) 1-2
2.Brest cancer patients scheduled to partial mastectomy with sentinel lymphadenectomy under general anesthesia
3. Age>=20
4. Written informed consent

Key exclusion criteria

1. Declinin to give informed consent
2. Body mass index (BMI) >=35/kg/m2
3. History of allergy to the medications used in the study
4. Contraindication to regional anesthesia (including coagulopathy and local infection)
5. Prior breast surgery except for diagnostic biopsies
6. History of treatment for a chronic pain condition and/or psychiatric disorder
7. Considered ineligible

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Sayaka Masuda

Organization

Tokyo Metropolitan Ohtsuka Hospital

Division name

Department of Anesthesiology

Zip code


Address

2-8-1, Minamiohtsuka, Toshima-ku, Tokyo

TEL

03+3941+3211(6098)

Email

mistysky_aaa@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Sayaka Masuda

Organization

Tokyo Metropolitan Ohtsuka Hospital

Division name

Department of Anesthesiology

Zip code


Address

2-8-1, Minamiohtsuka, Toshima-ku, Tokyo

TEL

03+3941+3211

Homepage URL


Email

mistysky_aaa@yahoo.co.jp


Sponsor or person

Institute

Tokyo Metropolitan Ohtsuka Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 02 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2015 Year 02 Month 15 Day

Date of IRB


Anticipated trial start date

2015 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 02 Month 12 Day

Last modified on

2016 Year 03 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019184


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name